Development of an implementation package for asthma medication optimisation in the emergency department (AMEND): an evidence, theory and person-based approach
Open Access
- 23 October 2026
- journal article
- Published by BMJ in BMJ Open Quality
- Vol. 15 (4) , e004306
Abstract
Salbutamol is the most commonly prescribed inhaler for adults discharged from the emergency department (ED) with uncontrolled asthma. However, newer options, for example, maintenance and reliever therapy, are now recommended due to growing concerns over risks linked to salbutamol overprescription. Transitioning to new inhalers requires support for both patients and healthcare professionals (HCPs). This paper outlines how we developed an implementation package based on evidence, theory and the person-based approach to support asthma medication optimisation in the ED. The purpose of this study was to use person-based intervention development methods in a three-phase process: (1) understanding behaviour—collating and synthesising evidence from in-depth interviews with the target population (patients and HCPs); secondary deductive analysis using the theoretical domains framework to understand barriers and facilitators to prescribing; developing guiding principles and logic model based on underlying theory; (2) identifying behavioural content and implementation options—behaviour change techniques were selected and translated into intervention content; (3) intervention materials developed and refined with input of stakeholders. We identified modifiable target behaviours for HCPs to support guideline-based care in the ED. These included identifying eligible patients, communicating rationale, providing patients with inhaler and resources and communicating changes to primary care. Key theoretical domains included knowledge, skills, addressing beliefs about consequences and targeting professional role perceptions. These domains were targeted through a clinical decision aid and training materials for ED HCP, template discharge summary for primary care and visual and written materials for patients. Minor refinements were made based on stakeholder feedback (six ED doctor think-aloud interviews; two patient workshops with eight and five participants respectively; and 12 survey responses to final draft of video). We developed an intervention grounded in theory, evidence and stakeholder feedback aimed at promoting and supporting delivery of guideline recommendations.Keywords
Funding Information
- Asthma UK Centre for Applied Research ([AUK-AC-2012-01 and AUK-AC-2018-01])
- AstraZeneca (Education grant)
This publication has 45 references indexed in Scilit:
- Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United StatesThe Journal of Allergy and Clinical Immunology: In Practice, 2023
- The ICS/Formoterol Reliever Therapy Regimen in Asthma: A ReviewJournal of Allergy and Clinical Immunology, 2023
- Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative studyRespiratory Medicine, 2020
- SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European CountriesAdvances in Therapy, 2020
- Scope and Influence of Electronic Health Record–Integrated Clinical Decision Support in the Emergency Department: A Systematic ReviewAnnals of Emergency Medicine, 2019
- Acceptability of a theory-based adherence intervention for adults with asthma – a person-based approachJournal of Asthma, 2019
- Supporting Adherence to Medicines for Long-Term ConditionsEuropean Psychologist, 2019
- UNDERSTANDING DISCHARGE COMMUNICATION BEHAVIOURS IN PEDIATRIC EMERGENCY CAREPaediatrics & Child Health, 2018
- Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East Londonnpj Primary Care Respiratory Medicine, 2016
- Using Animation to Improve Recovery from Acute Coronary Syndrome: A Randomized TrialAnnals of Behavioral Medicine, 2015